½ÃÀ庸°í¼­
»óǰÄÚµå
1193142

ÀüÀÚÈĵÎ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º) ½ÃÀå : À¯Çüº°(³»Àå ¹èÅ͸®, ¿ÜºÎ ¹èÅ͸®), ¿ëµµº°(ÈĵξÏ, ¾ð¾î ÀçȰ), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ) - ¼¼°è ±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2021-2031³â)

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀüÀÚÈĵÎÀÇ ¼¼°è ½ÃÀåÀº 2021³â¿¡ 4¾ï 950¸¸ ´Þ·¯, 2031³â¿¡´Â 7¾ï 300¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022³âºÎÅÍ 2031³â¿¡ °ÉÃÄ CAGR 5.5%·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÀüÀÚÈĵΠ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º)´Â »ç¶÷ÀÌ ¸»ÇÒ ¼ö ÀÖµµ·Ï ¼Ò¸®¸¦ ¹ß»ý½ÃŰ´Â ¹èÅ͸® ±¸µ¿ ÀåÄ¡ÀÔ´Ï´Ù. ´Ù¾çÇÑ ¸ÞÀÌÄ¿³ª ¸ðµ¨ÀÌ ÀÖ½À´Ï´Ù¸¸, ÀϹÝÀûÀ¸·Î´Â ¼ÒÇüÀÇ Àü±â ¸éµµ±â Á¤µµÀÇ Å©±âÀÔ´Ï´Ù. »ç¶÷ÀÌ ¸»ÇÏ°í ½ÍÀ» ¶§,ÀÌ ÀÛÀº ¹èÅ͸® ¼ÒǰÀ» ¸ñ ÅÎ ¾Æ·¡¿¡ Âø¿ëÇϽʽÿÀ. ¹öưÀ» ´©¸£¸é Áøµ¿ÀÌ ÇǺο¡¼­ ¸ñ¿¡ Àü´ÞµË´Ï´Ù. ±× ¼Ò¸®¸¦ ÀÔ, Çô, ÀÔ¼ú, Ä¡¾Æ·Î Ç¥ÇöÇÏ°í ¸»·Î ÇÕ´Ï´Ù.

Àΰø Èĵδ ¸ñ¼Ò¸®¸¦ ÀÒÀº »ç¶÷ÀÌ À½¼ºÀÇ Á֯ļö ÆÄ¶ó¹ÌÅ͸¦ Á¶Á¤Çϰí ÀúÀåÇÔÀ¸·Î½á ´õ ³ªÀº ¹ß¼ºÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ÀåÄ¡ÀÔ´Ï´Ù. À½¼º º¹¿ø ÀåÄ¡´Â Èĵζó°í ºÒ¸®´Â ¼º´ë Àüü¸¦ ¿µ±¸ÀûÀ¸·Î ÀýÁ¦ÇÏ°í ±â°ü°ú ½Äµµ¸¦ ºÐ¸®ÇÏ´Â ÈĵΠÀýÁ¦¼ú ÈÄ¿¡ °¡Àå Ȱ¿ëµË´Ï´Ù.

½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀº ÈĵξÏÀÇ À¯º´·ü Áõ°¡¿Í ¾ËÄڿðú ´ã¹è ¼ÒºñÀÇ ±ÞÁõÀº electrolarynx ½ÃÀåÀ» ±¸µ¿ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹¾ÏÇùȸ°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é 2022³â ¹Ì±¹¿¡¼­ ÈĵξϿ¡ ´ëÇØ¼­´Â »õ·Î ¾à 12,470¸í(³²¼º 9,820¸í, ¿©¼º 2,650¸í)ÀÌ ÈĵξÏÀ¸·Î »ç¸ÁÇÑ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù( 3,070 ³²¼º, 750 ¿©¼º). ¶ÇÇÑ, ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º(HPV)¿¡ ÀÇÇØ À¯¹ßµÇ´Â È£Èí±â À¯µÎÁ¾ÀÇ Áõ·Ê°¡ Áõ°¡ÇÏ´Â °ÍÀº º¸Åë ¾ç¼º(¾ÏÀÌ ¾Æ´Ô)ÀÓÀ» ³ªÅ¸³À´Ï´Ù. ÀÌ Á¾¾çÀº ¼º´ëÀÇ ¼Õ»ó°ú±âµµ ¹®Á¦·Î À̾îÁú ¼ö ÀÖÀ¸¸ç ÀüÀÚÈĵΠÀåÄ¡ÀÇ ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù. °Ô´Ù°¡ ÀÌ·¯ÇÑ ÀÇ·á±â±âÀÇ ³ôÀº ä¿ë·ü°ú Çõ½ÅÀûÀÌ°í ±â¼úÀûÀ¸·Î ÷´Ü ÀüÀÚÈĵÎÀåÄ¡ÀÇ Ãâ½Ã¸¦ À§ÇØ ¸¹Àº ¼±¼öµéÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁø ¿¹»óµË´Ï´Ù.

±×·¯³ª ÀüÀÚÈĵΠÀåÄ¡ÀÇ ºñ¿ëÀÌ ³ô´Ù´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÕ´Ï´Ù. ¹Ý´ë·Î ÇÏÀεξÏÀÇ Áõ·Ê¼ö Áõ°¡, ½ÅÈï±¹ÀÇ ÇコÄÉ¾î ½ÃÀåÀÇ ´ëµÎ, ±âº»ÀûÀÎ ÇコÄɾ ´ëÇÑ ¾×¼¼½º°¡ ¾ø´Â Àú¼Òµæ±¹°¡, ÈĵξÏÀÇ ¸®½ºÅ© Áõ°¡´Â ¿¹Ãø±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» À§ÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ÁÖ¿ä ÅõÀÚ Æ÷ÄÏ
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø ¿äÀÎ
    • ¾ïÁ¦ ¿äÀÎ
    • ±âȸ
  • COVID-19 ¿µÇ⠺м®

Á¦4Àå ÀüÀÚÈĵÎ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º) ½ÃÀå : À¯Çüº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ³»ÀåÇü ¹èÅ͸®
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ¿ÜÀå ¹èÅ͸®
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°

Á¦5Àå ÀüÀÚÈĵÎ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º) ½ÃÀå : ¿ëµµº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ÈĵξÏ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ¿¬¼³ ÀçȰ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°

Á¦6Àå ÀüÀÚÈĵÎ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • º´¿ø
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀΰú ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ±âŸ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°

Á¦7Àå ÀüÀÚÈĵÎ(ÀÏ·ºÆ®·Î·¡¸µÅ©½º) ½ÃÀå : Áö¿ªº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ºÏ¹Ì
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • À¯·´
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • À¯·´ÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • À¯·´ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ÀϺ»
      • Áß±¹
      • È£ÁÖ
      • Àεµ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • LAMEA
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿£µåÀ¯Àúº°
    • LAMEAÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ºê¶óÁú
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
      • ±âŸ LAMEA Áö¿ª

Á¦8Àå ±â¾÷ Á¤¼¼

  • ¼Ò°³
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»çÀÇ Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÇÕÀÇ È÷Æ® ¸Ê
  • ÁÖ¿ä ¹ßÀü

Á¦9Àå ±â¾÷ ÇÁ·ÎÇÊ

  • Ultravoice Limited
  • Inhealth Technologies
  • Griffin Labs
  • Servona GmbH
  • Labex Trade
  • AMPLICORD DI GABRIELLA SALVATORE
  • Romet Limted
  • Nu-Vois, LLC
  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Atos Medical AB
ksm 23.03.27

The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.

The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.

The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.

However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period. 

The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Built-in Battery
  • External Battery

By Application

  • Laryngeal Cancer
  • Speech Rehabilitation

By End user

  • Hospitals
  • Ambulatory Surgical Centers
  • others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Ultravoice Limited
    • Inhealth Technologies
    • Griffin Labs
    • Servona GmbH
    • Labex Trade
    • AMPLICORD DI GABRIELLA SALVATORE
    • Romet Limted
    • Nu-Vois, LLC
    • Andreas Fahl Medizintechnik - Vertrieb GmbH
    • Atos Medical AB

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Built-in Battery
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 External Battery
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Laryngeal Cancer
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Speech Rehabilitation
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End user
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End user
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End user
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Ultravoice Limited
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Inhealth Technologies
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Griffin Labs
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Servona GmbH
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Labex Trade
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 AMPLICORD DI GABRIELLA SALVATORE
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Romet Limted
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Nu-Vois, LLC
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Atos Medical AB
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦